C
CVRx, Inc. (CVRX)
NMS – Real Time Price. Currency in USD
5.27
-1.65 (-23.84%)
At close: May 12, 2026, 4:00 PM EDT
5.40
+0.13 (2.47%)
After-hours: May 12, 2026, 7:26 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
5.27
-1.65 (-23.84%)
At close: May 12, 2026, 4:00 PM EDT
5.40
+0.13 (2.47%)
After-hours: May 12, 2026, 7:26 PM EDT
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
| Name | Position |
|---|---|
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
| Mr. Brent Binkowski | Chief Operating Officer |
| Mr. Gregory Morrison | Chief Human Resources Officer |
| Mr. Jared Oasheim | Chief Financial Officer |
| Mr. Kevin Hykes | President, CEO & Director |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-12 | 10-Q | cvrx-20260331x10q.htm |
| 2026-05-11 | 8-K | tm2614163d1_8k.htm |
| 2026-04-20 | DEFA14A | ny20062360x2_defa14a.htm |
| 2026-04-13 | 8-K | tm2611335d1_8k.htm |
| 2026-03-03 | 8-K | tm267672d1_8k.htm |
| 2026-02-13 | 10-K | cvrx-20251231x10k.htm |
| 2026-02-12 | 8-K | tm266143d1_8k.htm |
| 2025-11-17 | DEL AM | tm2531452d1_delam.htm |
| 2025-11-06 | 10-Q | cvrx-20250930x10q.htm |
| 2025-11-05 | 8-K | tm2530302d1_8k.htm |
| Mr. Robert Allen John | Chief Revenue Officer |
| Ms. Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |